A phase II study of FOLFOXIRI with bevacizumab in untreated metastatic colorectal cancer patients: A UGT1A1 genotype and safety results (QUATTRO study)

Takeshi Kato; Takayuki Yoshino; Kei Muro; Kentaro Yamazaki; Tatsuro Yamaguchi; Eiji Oki; Shigeyoshi Iwamoto; Akihito Tsuji; Goro Nakayama; Yasunori Emi; Tetsuo Touyama; Masato Nakamura; Masahito Kotaka; Hideaki Bando; Yoshinori Kagawa; Hiroya Taniguchi; Takeharu Yamanaka; Akiyoshi Kanazawa

doi:10.1093/annonc/mdx263.023

A phase II study of FOLFOXIRI with bevacizumab in untreated metastatic colorectal cancer patients: A UGT1A1 genotype and safety results (QUATTRO study)

Takeshi Kato, Takayuki Yoshino, Kei Muro, Kentaro Yamazaki, Tatsuro Yamaguchi, Eiji Oki, Shigeyoshi Iwamoto, Akihito Tsuji, Goro Nakayama, Yasunori Emi, Tetsuo Touyama, Masato Nakamura, Masahito Kotaka, Hideaki Bando, Yoshinori Kagawa, Hiroya Taniguchi, Takeharu Yamanaka, Akiyoshi Kanazawa

Gastrointestinal Surgery (2)

Research output: Contribution to journal › Article › peer-review

5 Citations (Scopus)

Original language	English
Pages (from-to)	iii9-iii10
Journal	Annals of oncology : official journal of the European Society for Medical Oncology
Volume	28
DOIs	https://doi.org/10.1093/annonc/mdx263.023
Publication status	Published - Jun 1 2017

All Science Journal Classification (ASJC) codes

Hematology
Oncology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/annonc/mdx263.023

Cite this

Kato, T., Yoshino, T., Muro, K., Yamazaki, K., Yamaguchi, T., Oki, E., Iwamoto, S., Tsuji, A., Nakayama, G., Emi, Y., Touyama, T., Nakamura, M., Kotaka, M., Bando, H., Kagawa, Y., Taniguchi, H., Yamanaka, T., & Kanazawa, A. (2017). A phase II study of FOLFOXIRI with bevacizumab in untreated metastatic colorectal cancer patients: A UGT1A1 genotype and safety results (QUATTRO study). Annals of oncology : official journal of the European Society for Medical Oncology, 28, iii9-iii10. https://doi.org/10.1093/annonc/mdx263.023

A phase II study of FOLFOXIRI with bevacizumab in untreated metastatic colorectal cancer patients: A UGT1A1 genotype and safety results (QUATTRO study). / Kato, Takeshi; Yoshino, Takayuki; Muro, Kei et al.
In: Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 28, 01.06.2017, p. iii9-iii10.

Research output: Contribution to journal › Article › peer-review

Kato, T, Yoshino, T, Muro, K, Yamazaki, K, Yamaguchi, T, Oki, E, Iwamoto, S, Tsuji, A, Nakayama, G, Emi, Y, Touyama, T, Nakamura, M, Kotaka, M, Bando, H, Kagawa, Y, Taniguchi, H, Yamanaka, T & Kanazawa, A 2017, 'A phase II study of FOLFOXIRI with bevacizumab in untreated metastatic colorectal cancer patients: A UGT1A1 genotype and safety results (QUATTRO study)', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 28, pp. iii9-iii10. https://doi.org/10.1093/annonc/mdx263.023

@article{5b91de4867d649cdb2fa395acb491b66,

title = "A phase II study of FOLFOXIRI with bevacizumab in untreated metastatic colorectal cancer patients: A UGT1A1 genotype and safety results (QUATTRO study)",

author = "Takeshi Kato and Takayuki Yoshino and Kei Muro and Kentaro Yamazaki and Tatsuro Yamaguchi and Eiji Oki and Shigeyoshi Iwamoto and Akihito Tsuji and Goro Nakayama and Yasunori Emi and Tetsuo Touyama and Masato Nakamura and Masahito Kotaka and Hideaki Bando and Yoshinori Kagawa and Hiroya Taniguchi and Takeharu Yamanaka and Akiyoshi Kanazawa",

year = "2017",

month = jun,

day = "1",

doi = "10.1093/annonc/mdx263.023",

language = "English",

volume = "28",

pages = "iii9--iii10",

journal = "Annals of oncology : official journal of the European Society for Medical Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - A phase II study of FOLFOXIRI with bevacizumab in untreated metastatic colorectal cancer patients

T2 - A UGT1A1 genotype and safety results (QUATTRO study)

AU - Kato, Takeshi

AU - Yoshino, Takayuki

AU - Muro, Kei

AU - Yamazaki, Kentaro

AU - Yamaguchi, Tatsuro

AU - Oki, Eiji

AU - Iwamoto, Shigeyoshi

AU - Tsuji, Akihito

AU - Nakayama, Goro

AU - Emi, Yasunori

AU - Touyama, Tetsuo

AU - Nakamura, Masato

AU - Kotaka, Masahito

AU - Bando, Hideaki

AU - Kagawa, Yoshinori

AU - Taniguchi, Hiroya

AU - Yamanaka, Takeharu

AU - Kanazawa, Akiyoshi

PY - 2017/6/1

Y1 - 2017/6/1

UR - http://www.scopus.com/inward/record.url?scp=85045190756&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045190756&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdx263.023

DO - 10.1093/annonc/mdx263.023

M3 - Article

C2 - 32136059

SN - 0923-7534

VL - 28

SP - iii9-iii10

JO - Annals of oncology : official journal of the European Society for Medical Oncology

JF - Annals of oncology : official journal of the European Society for Medical Oncology

ER -

A phase II study of FOLFOXIRI with bevacizumab in untreated metastatic colorectal cancer patients: A UGT1A1 genotype and safety results (QUATTRO study)

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Cite this